---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-24-000035"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T05:10:19.605903+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q1 2024 revenue $323.5M (+8.7% YoY); GAAP EPS $0.48 (+35.5%)

## Summary
- Revenue $323.5M, up 8.7% YoY; constant currency revenue up 9.3%; organic constant currency up 7.0%.
- GAAP operating margin 11.1% vs 8.9% in Q1 2023; non-GAAP operating margin 17.3% vs 16.1%.
- GAAP EPS $0.48, up 35.5% from $0.36; non-GAAP EPS $0.77, up 18.7% from $0.64.
- Non-GAAP measures include constant currency and organic growth; reconciliations in press release.
- No specific guidance update provided; Q1 results discussed on April 30 conference call.

## SEC filing metadata
- accession: 0000856982-24-000035
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/0000856982-24-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/mmsi-20240430x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-24-000035
- JSON: https://secwatch.observer/filing/0000856982-24-000035.json
- Plain text: https://secwatch.observer/filing/0000856982-24-000035.txt

## Key facts
- Earnings Releases
  MERIT MEDICAL SYSTEMS INC reported first quarter ended March 31, 2024 results: revenue $323.5 million, EPS $0.48.
  - Period: first quarter ended March 31, 2024
  - Revenue: $323.5 million
  - EPS: $0.48
  - Result: reported results
  source text: mike.piccinino@westwicke.com ​ ​ ​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2024 ● Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023 ● Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023 ● Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023 ● Q1 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698224000035/0000856982-24-000035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.